Menu Search
Equities

Encompass Health Corp

EHC:NYQ

Encompass Health Corp

Actions
Health CareHealth Care Providers
  • Price (USD)92.06
  • Today's Change-0.39 / -0.42%
  • Shares traded582.53k
  • 1 Year change+33.61%
  • Beta0.8988
Data delayed at least 15 minutes, as of Sep 20 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy6
Outperform6
Hold0
Sell0
Strong Sell0

Share price forecast in USD

The 11 analysts offering 12 month price targets for Encompass Health Corp have a median target of 100.00, with a high estimate of 109.00 and a low estimate of 95.00. The median estimate represents a 8.62% increase from the last price of 92.06.
High18.4%109.00
Med8.6%100.00
Low3.2%95.00

Dividends in USD

In 2023, Encompass Health Corp reported a dividend of 0.60 USD, which represents a 30.23% decrease from last year. The 4 analysts covering the company expect dividends of 0.63 USD for the upcoming fiscal year, an increase of 5.00%.
Div growth (TTM)-30.23%
More ▼

Earnings history & estimates in USD

On Aug 05, 2024, Encompass Health Corp reported 2nd quarter 2024 earnings of 1.11 per share. This result exceeded the 1.01 consensus of the 12 analysts covering the company and exceeded last year's 2nd quarter results by 16.84%.
The next earnings announcement is expected on Oct 24, 2024.
Average growth rate+4.50%
Encompass Health Corp reported annual 2023 earnings of 3.64 per share on Feb 07, 2024.
Average growth rate+3.84%
More ▼

Revenue history & estimates in USD

Encompass Health Corporation had 2nd quarter 2024 revenues of 1.30bn. This missed the 1.30bn consensus estimate of the 11 analysts following the company. This was 12.13% above the prior year's 2nd quarter results.
Average growth rate+2.35%
Encompass Health Corporation had revenues for the full year 2023 of 4.80bn. This was 10.41% above the prior year's results.
Average growth rate+1.61%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.